What is Scotiabank’s Estimate for Nutrien Q4 Earnings?

Nutrien Ltd. (NYSE:NTR) – Research analysts at Scotiabank issued their Q4 2024 earnings estimates for Nutrien in a note issued to investors on Wednesday, January 29th. Scotiabank analyst B. Isaacson forecasts that the company will post earnings of $0.29 per share for the quarter. The consensus estimate for Nutrien’s current full-year earnings is $3.49 per share.

NTR has been the topic of a number of other reports. Oppenheimer began coverage on shares of Nutrien in a report on Thursday, December 12th. They set an “outperform” rating and a $60.00 price objective on the stock. CIBC reissued an “outperformer” rating and issued a $55.00 price target (down previously from $60.00) on shares of Nutrien in a research note on Tuesday, December 10th. Barclays reaffirmed an “equal weight” rating and set a $56.00 price objective (up from $55.00) on shares of Nutrien in a research report on Tuesday, January 21st. UBS Group lifted their target price on Nutrien from $51.00 to $53.00 and gave the company a “neutral” rating in a research report on Tuesday. Finally, Raymond James upgraded Nutrien from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $58.00 to $60.00 in a research note on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, six have given a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $58.94.

Nutrien Stock Performance

Shares of NTR stock opened at $51.65 on Thursday. The company has a market capitalization of $25.36 billion, a P/E ratio of 34.66, a price-to-earnings-growth ratio of 1.19 and a beta of 0.81. Nutrien has a 52 week low of $43.69 and a 52 week high of $60.87. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The company’s 50 day moving average price is $48.14 and its two-hundred day moving average price is $48.09.

Nutrien (NYSE:NTR) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business had revenue of $5.35 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same quarter last year, the company earned $0.35 earnings per share. The firm’s revenue was down 5.0% compared to the same quarter last year.

Nutrien Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 17th. Investors of record on Tuesday, December 31st were paid a $0.939 dividend. The ex-dividend date was Tuesday, December 31st. This is an increase from Nutrien’s previous quarterly dividend of $0.54. This represents a $3.76 annualized dividend and a dividend yield of 7.27%. Nutrien’s dividend payout ratio is 144.97%.

Institutional Investors Weigh In On Nutrien

Large investors have recently added to or reduced their stakes in the stock. Uncommon Cents Investing LLC raised its position in shares of Nutrien by 2.1% in the 4th quarter. Uncommon Cents Investing LLC now owns 11,550 shares of the company’s stock worth $517,000 after acquiring an additional 235 shares in the last quarter. Rhumbline Advisers raised its holdings in Nutrien by 3.5% in the fourth quarter. Rhumbline Advisers now owns 7,398 shares of the company’s stock worth $331,000 after purchasing an additional 247 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in shares of Nutrien by 6.5% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 4,309 shares of the company’s stock valued at $207,000 after buying an additional 263 shares during the last quarter. Meixler Investment Management Ltd. lifted its position in shares of Nutrien by 4.2% during the third quarter. Meixler Investment Management Ltd. now owns 7,159 shares of the company’s stock valued at $344,000 after buying an additional 288 shares during the last quarter. Finally, Atria Investments Inc boosted its holdings in shares of Nutrien by 2.0% in the 3rd quarter. Atria Investments Inc now owns 14,636 shares of the company’s stock valued at $703,000 after buying an additional 290 shares in the last quarter. Institutional investors and hedge funds own 63.10% of the company’s stock.

About Nutrien

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.